El Catálogo Colectivo reúne los registros del material que posee cada una de las
bibliotecas de la Universidad Nacional de Córdoba, pudiendo encontrarse colecciones
especializadas y actualizadas en todas las áreas del conocimiento; lo que permite una
amplia visibilidad y garantiza el acceso al patrimonio documental de la Universidad.
Se encuentra disponible para toda la comunidad académica: estudiantes, docentes,
egresados e investigadores.
Si formas parte de la comunidad de la UNC también podés solicitar préstamos de material,
a cualquier biblioteca universitaria, utilizando el servicio de préstamo interbibliotecario,
independientemente de la facultad a la que pertenezcas, la carrera que curses o la cátedra
que dictes.
The indian pharmaceutical sector : issues and options for health sector reform
This report assesses the pharmaceutical sector in India, particularly focusing on four key issues related to the production, procurement, and distribution of drugs in India: a) availability, b) affordability; c) quality, and d) the rational use of drugs. The results of a survey of three states indic...
|a The indian pharmaceutical sector :
|b issues and options for health sector reform
|c / Ramesh Govindaraj, Gnanaraj Chellaraj
260
|b World Bank
|a Washington, D.C.
|c 2002
300
|a xiii, 59 p. :
|b il.
490
|a World Bank discussion paper
|v no. 437
|x 0259-210X
500
|a Incluye glosario
504
|a Incluye bibliografía
505
|a Abstract -- Preface -- Acknowledgments -- List of abbreviations and acronyms -- 1. Introduction -- 2. Review of literature -- 3. Methodology -- 4. Overview of the Indian pharmaceutical sector -- 5. Recent initiatives: 1994-1995 national pharmaceutical policy -- 6. Policy outcomes -- 7. Other implications of the recent changes in pharmaceuticals policy -- 8. Key health-related issues in the pharmaceutical sector -- 9. Recommendations -- Annex: Pharmaceutical survey questionnaire -- Glossary -- References.
520
|a This report assesses the pharmaceutical sector in India, particularly focusing on four key issues related to the production, procurement, and distribution of drugs in India: a) availability, b) affordability; c) quality, and d) the rational use of drugs. The results of a survey of three states indicate considerable variation across states in the above four areas in both public and private sectors. The report concludes that problems with the availability, affordability, and rational use of good quality, cost-effective, essential drugs have persisted in most parts of India, and that these health-related issues need be addressed as a priority. An overarching recommendation is the need to focus on strengthening the implementation and regulation of the pharmaceutical sector at the state level, rather than on simply introducing new regulations. Adequate pharmaceutical quality assurance needs to be particularly emphasized as, in its absence, other reform measures could be rendered moot. Similarly, the rational use of drugs needs to be emphasized as it is likely to yield significant cost savings to the government and to consumers, in addition to its positive impact on health.
